PuZhong Discovery

PuZhong Discovery is a China-based biotechnology company focused on the discovery and development of innovative small molecule therapeutics. The company leverages a proprietary drug discovery platform that integrates structure-based drug design (SBDD) with advanced computational tools to target high-value biological pathways in oncology and immunology. PuZhong Discovery aims to address unmet medical needs by developing next-generation inhibitors with improved selectivity and potency. The firm operates primarily in the pre-clinical stage, advancing a pipeline of internal programs while seeking strategic collaborations for further development.